DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20184415

Clinical and doppler monitoring of patients with Takayasu arteritis with ITAS 2010 and CDUS-K score respectively following medical intervention: a 12 months follow-up study

Debanjali Sinha, Sumantro Mondal, Arijit Nag, Debasish Lahiri, Alakendu Ghosh

Abstract


Background: The objective of the present study was to monitor the disease activity of Takayasu arteritis clinically by the Indian Takayasu Activity Score 2010 (ITAS) and ultra sonographically by Colour Doppler Ultrasound-Kolkata (CDUS-K) Score after 12months of treatment with methotrexate and steroid, and to find the correlation between these two scores.

Methods: Around 25 Angiographically proven Takayasu arteritis patients were treated with Methotrexate (15mg weekly) and Steroids (1mg/kg/day for 6weeks and then tapered) for 12months. Wilcoxon matched pair signed rank test was done to assess the change in ITAS 2010 with treatment. A correlation study was done between ITAS 2010 and change in CDUS-K scores at the end of 12months.

Results: By Wilcoxon’s matched pair signed rank test, a non-significant change of ITAS 2010 (p=0.066) was observed at the end of 12months, which means that the treatment helps to control the disease progression by preventing a significant increase in ITAS 2010. Strong correlation (correlation coefficient of 0.878, 95% CI = 0.602 to 1.000) was found between the ITAS 2010 and change in CDUS-K scores at 12months follow up.

Conclusions: The combination of Methotrexate and steroids helps to control the disease progression in Takayasu arteritis. Colour doppler ultrasonography may serve as a reliable and safe surrogate disease activity measure at follow up, as it avoids the radioactivity exposure and invasiveness of angiography.


Keywords


CDUS-K, Follow-up, ITAS 2010, Takayasu arteritis

Full Text:

PDF

References


Lupi-Herrera E, Sanchez-Torres G, Marcushamer J, Mispireta J, Horwitz S, Vela JE. Takayasu's arteritis. Clinical study of 107 cases. Am Heart J. 1977 Jan;93(1):94-103.

Numano F, Okawara M, Inomata H, Kobayashi Y. Takayasu's arteritis. Lancet. 2000;356(9234):1023-5.

Misra R, Danda D, Rajappa SM, Ghosh A, Gupta R, Mahendranath KM, et al. Development and initial validation of the Indian Takayasu clinical activity score (ITAS2010). Rheumatol. 2013 Apr 16;52(10):1795-801.

Sinha D, Mondal S, Nag A, Ghosh A. Development of a colour Doppler ultrasound scoring system in patients of Takayasu's arteritis and its correlation with clinical activity score (ITAS 2010). Rheumatology (Oxford). 2013; 52(12):2196-202.

Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheumatism. 1990 Aug;33(8):1129-34.

Park MC, Lee SW, Park YB, Chung NS, Lee SK. Clinical characteristics and outcomes of Takayasu's arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment, and angiographic classification. Scand J Rheumatol. 2005 Jan 1;34(4):284-92.

Hoffman GS, Ahmed AE. Surrogate markers of disease activity in patients with Takayasu arteritis: a preliminary report from The International Network for the Study of the Systemic Vasculitides (INSSYS) 1. Int J Cardiol. 1998 Oct 1;66:S191-4.

Salvarani C, Cantini F, Boiardi L, Hunder GG. Laboratory investigations useful in giant cell arteritis and Takayasu's arteritis. Clinical Experimental Rheumatol. 2003 Nov 1;21(6; SUPP/32):S23-8.

Goel R, Danda D, Mathew J, Edwin N. Mycophenolate mofetil in Takayasu's arteritis. Clin Rheumatol. 2010;29(3):329-32.

Salvarani C, Magnani L, Catanoso M, Pipitone N, Versari A, Dardani L, et al. Tocilizumab: a novel therapy for patients with large-vessel vasculitis. Rheumatology. 2011 Nov 9;51(1):151-6.

Hall S, Barr W, Lie JT, Stanson AW, Kazmier FJ, Hunder GG. Takayasu arteritis. A study of 32 North American patients. Medicine. 1985 Mar;64(2):89-99.

Del LC, Moruzzo D, Agelli M, Pentimone F. Takayasu's arteritis on steroid therapy. Seven years follow-up. Panminerva Medica. 1999 Dec;41(4):355-8.

Mwipatayi BP, Jeffery PC, Beningfield SJ, Matley PJ, Naidoo NG, Kalla AA, et al. Takayasu arteritis: clinical features and management: report of 272 cases. ANZ J Surgery. 2005 Mar;75(3):110-7.

Maeda H, Handa N, Matsumoto M, Hougaku H, Ogawa S, Oku N, et al. Carotid lesions detected by B-mode ultrasonography in Takayasu's arteritis: “macaroni sign” as an indicator of the disease. Ultrasound Med Biol. 1991 Jan 1;17(7):695-701.

Lefebvre C, Rance A, Paul JF, Beguin C, Bletry O, Amoura Z, et al. The role of B-mode ultrasonography and electron beam computed tomography in evaluation of Takayasu's arteritis: a study of 43 patients. Seminars Arthritis Rheumatism 2000 Aug 1; 30(1):25-32.

Taniguchi N, Itoh K, Honda M, Obayashi T, Nakamura M, Kawai F, et al. Comparative ultrasonographic and angiographic study of carotid arterial lesions in Takayasu's arteritis. Angiology. 1997 Jan;48(1):9-20.

Schmidt WA, Nerenheim A, Seipelt E, Poehls C, Gromnica-Ihle E. Diagnosis of early Takayasu arteritis with sonography. Rheumatology (Oxford). 2002;41(5):496-502.

Kissin EY, Merkel PA. Diagnostic imaging in Takayasu arteritis. Current Opinion Rheumatol. 2004 Jan 1;16(1):31-7.

19. Bacon P, Direskeneli H. Quantifying disease involvement in Takayasu's arteritis. Rheumatology (Oxford). 2014; 53(9):1535-6.

Tatsumi M, Cohade C, Nakamoto Y, Wahl RL. Fluorodeoxyglucose uptake in the aortic wall at PET/CT: possible finding for active atherosclerosis. Radiology. 2003 Dec;229(3):831-7.